Amalgamated Bank Dynavax Technologies Corp Transaction History

Amalgamated Bank

$13.6 Billion
Q3 2025

A detailed history of Amalgamated Bank transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Amalgamated Bank holds 28,810 shares of DVAX stock, worth $299,624. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,810

Previous 32,650 11.76%

Holding current value

$299,624

Previous $323,000 11.46%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 29, 2025	SELL	$9.36 - $11.36 $35,942 - $43,622	-3,840 Reduced 11.76%	28,810 $286,000
Q2 2025 Aug 04, 2025	SELL	$9.4 - $12.87 $24,853 - $34,028	-2,644 Reduced 7.49%	32,650 $323,000
Q1 2025 Apr 25, 2025	SELL	$12.39 - $14.4 $9,280 - $10,785	-749 Reduced 2.08%	35,294 $458,000
Q4 2024 Feb 04, 2025	BUY	$10.28 - $13.66 $3,484 - $4,630	339 Added 0.95%	36,043 $460,000
Q3 2024 Oct 30, 2024	SELL	$10.05 - $11.61 $43,044 - $49,725	-4,283 Reduced 10.71%	35,704 $398,000
Q2 2024 Aug 12, 2024	BUY	$10.73 - $12.58 $1,201 - $1,408	112 Added 0.28%	39,987 $449,000
Q1 2024 Apr 23, 2024	SELL	$11.7 - $14.98 $172,621 - $221,014	-14,754 Reduced 27.01%	39,875 $495,000
Q4 2023 Feb 06, 2024	SELL	$13.09 - $14.98 $16,912 - $19,354	-1,292 Reduced 2.31%	54,629 $764,000
Q3 2023 Nov 08, 2023	BUY	$12.64 - $14.99 $18,429 - $21,855	1,458 Added 2.68%	55,921 $826,000
Q2 2023 Aug 11, 2023	BUY	$9.85 - $13.17 $1,782 - $2,383	181 Added 0.33%	54,463 $703,000
Q1 2023 May 02, 2023	SELL	$9.44 - $11.88 $34,248 - $43,100	-3,628 Reduced 6.26%	54,282 $533,000
Q4 2022 Feb 10, 2023	BUY	$10.27 - $13.29 $7,445 - $9,635	725 Added 1.27%	57,910 $616,000
Q3 2022 Nov 09, 2022	BUY	$9.93 - $17.44 $5,650 - $9,923	569 Added 1.01%	57,185 $597,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $290,810 - $500,819	39,035 Added 222.03%	56,616 $713,000
Q1 2022 Jun 30, 2022	SELL	$9.75 - $14.44 $13,562 - $20,086	-1,391 Reduced 7.33%	17,581 $191,000
Q4 2021 Feb 15, 2022	SELL	$13.17 - $20.94 $3,700 - $5,884	-281 Reduced 1.46%	18,972 $267,000
Q3 2021 Oct 29, 2021	SELL	$9.16 - $19.83 $10,140 - $21,951	-1,107 Reduced 5.44%	19,253 $370,000
Q2 2021 Aug 16, 2021	BUY	$7.25 - $10.99 $46,160 - $69,973	6,367 Added 45.5%	20,360 $201,000
Q1 2021 May 13, 2021	SELL	$4.57 - $11.18 $5,813 - $14,220	-1,272 Reduced 8.33%	13,993 $138,000
Q4 2020 Feb 12, 2021	BUY	$3.73 - $5.6 $276 - $414	74 Added 0.49%	15,265 $67,000
Q3 2020 Oct 30, 2020	BUY	$4.32 - $11.7 $8,415 - $22,791	1,948 Added 14.71%	15,191 $66,000
Q2 2020 Aug 10, 2020	SELL	$2.94 - $9.1 $1,358 - $4,204	-462 Reduced 3.37%	13,243 $117,000
Q1 2020 May 13, 2020	SELL	$2.27 - $6.2 $735 - $2,008	-324 Reduced 2.31%	13,705 $48,000
Q4 2019 Feb 13, 2020	BUY	$3.46 - $6.93 $8,445 - $16,916	2,441 Added 21.06%	14,029 $80,000
Q3 2019 Nov 13, 2019	SELL	$2.69 - $4.85 $277 - $499	-103 Reduced 0.88%	11,588 $41,000
Q2 2019 Aug 14, 2019	BUY	$3.65 - $7.89 $42,672 - $92,241	11,691 New	11,691 $47,000

Others Institutions Holding DVAX

# of Institutions

295

Shares Held

120M

Call Options Held

294K

Put Options Held

86.1K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.32B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Dynavax Technologies Corp Transaction History